These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24675587)

  • 1. Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.
    Thapa DR; Hussain SK; Tran WC; Dʼsouza G; Bream JH; Achenback CJ; Ayyavoo V; Detels R; Martínez-Maza O
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):229-37. PubMed ID: 24675587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
    Hussain SK; Zhu W; Chang SC; Breen EC; Vendrame E; Magpantay L; Widney D; Conn D; Sehl M; Jacobson LP; Bream JH; Wolinsky S; Rinaldo CR; Ambinder RF; Detels R; Zhang ZF; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):295-307. PubMed ID: 23250934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas.
    Thapa DR; Li X; Jamieson BD; Martínez-Maza O
    PLoS One; 2011; 6(6):e20781. PubMed ID: 21698185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.
    Gopal S; Patel MR; Yanik EL; Cole SR; Achenbach CJ; Napravnik S; Burkholder GA; Reid EG; Rodriguez B; Deeks SG; Mayer KH; Moore RD; Kitahata MM; Eron JJ; Richards KL
    J Natl Cancer Inst; 2013 Aug; 105(16):1221-9. PubMed ID: 23892362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.
    Fang C; Zhu DX; Dong HJ; Zhou ZJ; Wang YH; Liu L; Fan L; Miao KR; Liu P; Xu W; Li JY
    Ann Hematol; 2012 Apr; 91(4):553-9. PubMed ID: 21987025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
    Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
    Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.
    Vendrame E; Hussain SK; Breen EC; Magpantay LI; Widney DP; Jacobson LP; Variakojis D; Knowlton ER; Bream JH; Ambinder RF; Detels R; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):343-9. PubMed ID: 24220912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
    Baraniskin A; Kuhnhenn J; Schlegel U; Chan A; Deckert M; Gold R; Maghnouj A; Zöllner H; Reinacher-Schick A; Schmiegel W; Hahn SA; Schroers R
    Blood; 2011 Mar; 117(11):3140-6. PubMed ID: 21200023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
    Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI
    J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma.
    Sei S; O'Neill DP; Stewart SK; Yang Q; Kumagai M; Boler AM; Adde MA; Zwerski SL; Wood LV; Venzon DJ; Magrath IT
    Cancer Res; 2001 Jul; 61(13):5028-37. PubMed ID: 11431337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
    Epeldegui M; Magpantay L; Guo Y; Halec G; Cumberland WG; Yen PK; Macatangay B; Margolick JB; Rositch AF; Wolinsky S; Martinez-Maza O; Hussain SK
    AIDS; 2018 Apr; 32(7):945-954. PubMed ID: 29424776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
    Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
    J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
    Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
    Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma.
    Nolen BM; Breen EC; Bream JH; Jenkins FJ; Kingsley LA; Rinaldo CR; Lokshin AE
    PLoS One; 2014; 9(6):e99144. PubMed ID: 24922518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States.
    Howlader N; Shiels MS; Mariotto AB; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1289-96. PubMed ID: 27418269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.
    Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M
    AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients.
    Song G; Gu L; Li J; Tang Z; Liu H; Chen B; Sun X; He B; Pan Y; Wang S; Cho WC
    Ann Hematol; 2014 Oct; 93(10):1735-43. PubMed ID: 24858372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.